MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Dermatology and Skin Diseases
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,536 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,536 works in the cohort · of 4,299,418page 37 of 51

Labels cover 6 of 2,536 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,536 of 2,536 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

aboutno affunlabeled
Dupilumab (Dupixent)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
affno abstractunlabeled
SYCOSIS BARBÆ
HENRY C.G. SEMON
2013· book-chapter· en· Elsevier eBooks· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Tralokinumab (Adtralza)
CADTH
2022· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
venueno affno abstractunlabeled
POST-TRAUMATIC ECZEMA
Haydee Ramirez de Knott, James S. Taylor
2006· article· en· Dermatitis· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
affunlabeled
Harmonizing body surface area assessments between the Eczema Area and Severity Index, <scp>SCORing</scp> Atopic Dermatitis, and handprint methods utilizing one shared <scp>measurement—A</scp> proposal to improve efficiency and reduce error in atopic dermatitis trials
M. E. Jacobson, R. Seshadri, Robert Bissonnette, Amy S. Paller, Stephan Weidinger, Jacob P. Thyssen +2 more
2024· letter· en· Journal of the European Academy of Dermatology and Venereology· Medicine
machine prediction:candidate · metaresearchconsensus · none
0
citations
affno abstractunlabeled
42262 Sustained Improvement Over 52 Weeks in Patient-Reported Itch, Symptoms, and Quality of Life With Upadacitinib in Patients With Atopic Dermatitis: Results From Phase 3 Studies (Measure Up 1, Measure Up 2, and AD Up)
Jonathan I. Silverberg, Mette Deleuran, Linda Stein Gold, Christopher G. Bunick, DirkJan Hijnen, Brian Calimlim +5 more
2023· article· en· Journal of the American Academy of Dermatology· Medicine
machine prediction:candidate · noneconsensus · none
0
citations

How this was built: Screen · Findings · About